TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25074771

Group type: EXPERIMENTAL
Intervention: Lutein 20 mg/d
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Lutein 20 mg/d (in patients with low plasma lutein)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (in patients with low plasma lutein)
Number of subjects: 39
Study: 23182475

Group type: EXPERIMENTAL
Intervention: Deslorelin acetate (100 μg IM every 12h)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 56
Study: 19762523

Group type: EXPERIMENTAL
Intervention: Specific strength training of the neck/shoulder muscles
Number of subjects: 42

Group type: COMPARATOR
Intervention: General fitness training performed as leg-bicycling
Number of subjects: 42

Group type: COMPARATOR
Intervention: Reference intervention without physical activity
Number of subjects: 42
Study: 17520465

Group type: EXPERIMENTAL
Intervention: Ciclopirox olamine (1.5%) shampoo
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Ketoconazole (2.0%) shampoo
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 16818930

Group type: COMPARATOR
Intervention: Active treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 12560148

Group type: EXPERIMENTAL
Intervention: Preparation book for surgery (experimental group)
Number of subjects: 400

Group type: COMPARATOR
Intervention: No preparation book (control group)
Number of subjects: 400
Study: 10221357

Group type: EXPERIMENTAL
Intervention: 40 mg propranolol hydrochloride
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 40 mg nadolol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 8730629

Group type: EXPERIMENTAL
Intervention: Corticosteroid + IUI (n = 18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: IUI alone (n = 18)
Number of subjects: 36
Study: 1856403

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 378

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study: 6336708

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 30503232

Group type: EXPERIMENTAL
Intervention: Game-based intervention
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard EMG training (MyoBoy)
Number of subjects: 14
Study: 27247166

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided cannulation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Palpation technique
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106
Study: 27347553

Group type: COMPARATOR
Intervention: Colgate Cavity Protection (1000 ppmF‐MFP)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sensodyne Total Care (1000 ppmF‐NaF + 19300 ppmK(+)‐KNO3)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Clinpro Tooth Crème (950 ppmF‐NaF + fTCP)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Clinpro Tooth Crème (brushing + additional topical application)
Number of subjects: 71
Study: 22930148

Group type: EXPERIMENTAL
Intervention: Low-dose magnesium sulphate (9 g loading dose: 4 g iv and 5 g im; maintenance 2.5 g im every 4 hours for 24 hours)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard dose magnesium sulphate (14 g loading dose; maintenance 5 g im every 4 hours)
Number of subjects: 72
Study: 20633669

Group type: EXPERIMENTAL
Intervention: Patient education and supervised exercise (PE+SE)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Patient education alone (PE)
Number of subjects: 109
Study: 18155339

Group type: EXPERIMENTAL
Intervention: Intention-to-reverse condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive condition
Number of subjects: 0
Study: 15942259

Group type: EXPERIMENTAL
Intervention: Estradiol (2 mg estradiol valerate)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Estradiol plus progesterone (100 mg micronized progesterone)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 12917302

Group type: EXPERIMENTAL
Intervention: Methotrexate (15 mg per week)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Cyclosporine (3 mg per kilogram of body weight per day)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 88

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Methotrexate and Cyclosporine
Number of subjects: 88
Study: 10566922

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 80
Study: 8762389

Group type: EXPERIMENTAL
Intervention: Personal health education given every four months
Number of subjects: 688

Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 688
Study: 1817625

Group type: EXPERIMENTAL
Intervention: Air
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 50
Study: 6225508

Group type: EXPERIMENTAL
Intervention: Streptozotocin, mitomycin C, and 5‐FU (SMF)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Mitomycin C and 5‐FU (MF)
Number of subjects: 116
Study: 31992495

Group type: EXPERIMENTAL
Intervention: Pregabalin (300 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31034251

Group type: EXPERIMENTAL
Intervention: PS-W (daily consumption of margarine containing 2 g/day of plant sterols with 30-min daily walking)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PS-W
Number of subjects: 15

Group type: COMPARATOR
Intervention: C-S (daily consumption of control margarine while sedentary)
Number of subjects: 15

Group type: COMPARATOR
Intervention: PS-S (daily consumption of margarine containing 2 g/day of plant sterols while sedentary)
Number of subjects: 15

Group type: COMPARATOR
Intervention: C-W (daily consumption of control margarine with 30-min daily walking)
Number of subjects: 15
Study: 28544241

Group type: EXPERIMENTAL
Intervention: RRR-α-tocopherol supplementation (400 IU single dose)
Number of subjects: 50
Study: 26592221

Group type: EXPERIMENTAL
Intervention: Pilates method (PG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: General exercise (GEG)
Number of subjects: 22
Study: 23937010

Group type: EXPERIMENTAL
Intervention: Myrtol Standardized Enteric Coated Soft Capsules, 0.3 g, 3 times a day, for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Myrtol Standardized Enteric Coated Soft Capsules
Number of subjects: 60
Study: 21398682

Group type: EXPERIMENTAL
Intervention: Intervention group (IVAC educational methodology)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 19858871

Group type: EXPERIMENTAL
Intervention: Auditory stimulation during surgery (pure tones via headphones)
Number of subjects: 87

Group type: COMPARATOR
Intervention: No auditory stimulation (control group)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: General anesthesia (induced with thiopental and maintained with fentanyl and sevoflurane)
Number of subjects: 87
Study: 17031646

Group type: EXPERIMENTAL
Intervention: CP‐547,632 plus paclitaxel (225 mg/m²) and carboplatin (AUC = 6) every 3 weeks
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: CP‐547,632 plus chemotherapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Chemotherapy alone (paclitaxel and carboplatin)
Number of subjects: 70
Study: 14615471

Group type: EXPERIMENTAL
Intervention: BIA 3-202 (50 mg, 100 mg, 200 mg twice daily and 200 mg thrice daily)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: BIA 3-202
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 10754780

Group type: EXPERIMENTAL
Intervention: E2 supplementation (2 mg two times daily) from the early proliferative phase to the late secretory phase of the endometrium
Number of subjects: 81

Group type: COMPARATOR
Intervention: No E2 supplementation (control group)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: E2 supplementation (2 mg two times daily)
Number of subjects: 81
Study: 9105958

Group type: EXPERIMENTAL
Intervention: Major depressives
Number of subjects: 257

Group type: COMPARATOR
Intervention: Bipolar patients
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Psychopathology
Number of subjects: 257
Study: 1541787

Group type: EXPERIMENTAL
Intervention: Elemental dietary formula (amino acid)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Polymeric dietary formula (intact protein isolates)
Number of subjects: 30
Study: 3872835

Group type: EXPERIMENTAL
Intervention: Nicardipine (7.5 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Verapamil (16 mg)
Number of subjects: 30
Study: 28961380

Group type: EXPERIMENTAL
Intervention: Active treatment (magnetic stimulation)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 39
Study: 27924392

Group type: EXPERIMENTAL
Intervention: Colonic stenting as a bridge to surgery (SBTS)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Emergency surgery (ES)
Number of subjects: 115
Study: 26100611

Group type: EXPERIMENTAL
Intervention: HORIZON trauma focused cognitive behavioral therapy with parental components
Number of subjects: 100
Study: 21193320

Group type: EXPERIMENTAL
Intervention: Edwards Perimount Magna (EPM)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Medtronic Mosaic (MM)
Number of subjects: 108
Study: 19665587

Group type: EXPERIMENTAL
Intervention: acyclovir 400mg BD
Number of subjects: 1305

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1305
Study: 17884623

Group type: EXPERIMENTAL
Intervention: 3% POL foam
Number of subjects: 148

Group type: COMPARATOR
Intervention: 1% POL foam
Number of subjects: 148
Study: 15136099

Group type: EXPERIMENTAL
Intervention: Endometrial sampling and measurement of serum estradiol and progesterone 1 to 14 days after the midcycle urinary luteinizing hormone surge.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Traditional dating criteria and histologic features analysis.
Number of subjects: 130
Study: 11841079

Group type: EXPERIMENTAL
Intervention: Gastrografin 200 ml orally for 2 consecutive days before operation
Number of subjects: 58

Group type: COMPARATOR
Intervention: Ringer's solution through a nasogastric tube
Number of subjects: 58
Study: 10463377

Group type: EXPERIMENTAL
Intervention: 30 mg physostigmine patch
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: 60 mg physostigmine patch
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 204
Study: 7595767

Group type: EXPERIMENTAL
Intervention: Neonatal amino acid formulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: General-purpose intravenous amino acid solution
Number of subjects: 20
Study: 2195722

Group type: EXPERIMENTAL
Intervention: Vincristine
Number of subjects: 92

Group type: COMPARATOR
Intervention: No vincristine
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Vincristine (high-risk patients)
Number of subjects: 92

Group type: COMPARATOR
Intervention: No vincristine (high-risk patients)
Number of subjects: 92
Study: 517815

Group type: EXPERIMENTAL
Intervention: Diluent
Number of subjects: 3

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3

Group type: COMPARATOR
Intervention: Time
Number of subjects: 3

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 3
Study: 31613877

Group type: EXPERIMENTAL
Intervention: Documented bladder diverticulum (BD)
Number of subjects: 10662

Group type: COMPARATOR
Intervention: Non-BD subjects (comparison cohort)
Number of subjects: 10662
Study: 28202013

Group type: EXPERIMENTAL
Intervention: Clarithromycin-based sequential treatment (10-day regimen: Proton-Pump Inhibitor + Amoxicillin 1 g bid for 5 days and Proton-Pump Inhibitor + Clarithromycin 500 mg + Metronidazole/Tinidazole 500 mg bid/tid for the following 5 days)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Levofloxacin-based sequential treatment (10-day modified regimen with Levofloxacin 500 mg id instead of Clarithromycin)
Number of subjects: 200
Study: 26004882

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5mg the night before surgery
Number of subjects: 478

Group type: EXPERIMENTAL
Intervention: Alprazolam 0.5mg the morning of surgery
Number of subjects: 478

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 478
Study: 22799528

Group type: EXPERIMENTAL
Intervention: Extraction treatment (Group 1)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Nonextraction treatment (Group 2)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Untreated group (Group 3)
Number of subjects: 269
Study: 21492764

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg daily
Number of subjects: 17802

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17802

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg daily (without LDL-C <50 mg/dl)
Number of subjects: 17802
Study: 19699857

Group type: EXPERIMENTAL
Intervention: 150 x 10(6) BMMNCs on day 3 post-AMI
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 150 x 10(6) BMMNCs on day 7 post-AMI
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo on day 3 post-AMI
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo on day 7 post-AMI
Number of subjects: 120
Study: 17129389

Group type: EXPERIMENTAL
Intervention: Mydriatic drops (Tropicamide 1%, Phenylephrine 2.5%, Diclofenac sodium 0.1%)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Depot method (wick soaked in the same drop mixture)
Number of subjects: 130
Study: 12594144

Group type: EXPERIMENTAL
Intervention: Tramadol 5% (Group T, n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prilocaine 2% (Group P, n=30)
Number of subjects: 60
Study: 11212860

Group type: EXPERIMENTAL
Intervention: Zona thinning (ZT) using a laser diode with 1.48‐micron wavelength (Fertilaser)
Number of subjects: 103

Group type: COMPARATOR
Intervention: No zona thinning (Control group)
Number of subjects: 103
Study: 8889317

Group type: EXPERIMENTAL
Intervention: Propranolol (PRO) 80 mg x 2/day for 7 days
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Pindolol (PIN) 10 mg x 2/day for 7 days
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 7
Study: 1824585

Group type: EXPERIMENTAL
Intervention: Ephedrine (0.5 mg/kg)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Droperidol (0.04 mg/kg)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 97
Study: 6407438

Group type: EXPERIMENTAL
Intervention: Diltiazem 240 or 360 mg/day
Number of subjects: 42
Study: 2883817

Group type: EXPERIMENTAL
Intervention: temazepam (20 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: flunitrazepam (2 mg/day)
Number of subjects: 100
Study: 29084042

Group type: EXPERIMENTAL
Intervention: Local drug delivery of abciximab (IL, by the ClearWay catheter) plus aspiration thrombectomy (AT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nonlocal drug delivery of abciximab (IC, by the guide catheter) plus aspiration thrombectomy (AT)
Number of subjects: 59
Study: 26971071

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy for psychosis based Guided Self-help (CBTp-GSH)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 33
Study: 23906195

Group type: EXPERIMENTAL
Intervention: Atrial electromechanical interval (AEMI)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Left atrial volume index (LAVI)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Peak myocardial velocity during late diastole (a')
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: AEMI
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Age, use of antiarrhythmic drugs, and AEMI
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: LAVI and a'
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 108
Study: 22252094

Group type: EXPERIMENTAL
Intervention: imipramine+clinical management (IMI‐CM)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Cognitive‐Behavioral Therapy (CBT)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 250

Group type: COMPARATOR
Intervention: pill placebo (PLA‐CM)
Number of subjects: 250
Study: 20235065

Group type: EXPERIMENTAL
Intervention: Hybrid hip resurfacing (HR)
Number of subjects: 209

Group type: COMPARATOR
Intervention: 28 mm total hip arthroplasty (THA)
Number of subjects: 209
Study: 18322988

Group type: EXPERIMENTAL
Intervention: Somatic absorption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychiatric distress
Number of subjects: 0
Study: 16124422

Group type: EXPERIMENTAL
Intervention: 4 mg/kg/day of artesunate for 3 days and 3 daily doses of 8.0 mg/kg/day mefloquine
Number of subjects: 120

Group type: COMPARATOR
Intervention: 4 mg/kg/day of artesunate for 3 days and mefloquine given as 15 mg/kg on the first day and 10 mg/kg on the second day
Number of subjects: 120
Study: 14506624

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 66
Study: 11018188

Group type: EXPERIMENTAL
Intervention: Tirofiban plus heparin
Number of subjects: 105

Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 105
Study: 9479799

Group type: EXPERIMENTAL
Intervention: Telephone prompt by a non-medical research assistant
Number of subjects: 364

Group type: COMPARATOR
Intervention: Conventional mail-outs (Control)
Number of subjects: 364
Study: 1832344

Group type: EXPERIMENTAL
Intervention: ANF 99-126 3 pmol/kg/min
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: ANF 99-126 10 pmol/kg/min
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: ANF 103-126 3 pmol/kg/min
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: ANF 103-126 10 pmol/kg/min
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (5% D-glucose)
Number of subjects: 33
Study: 6342784

Group type: EXPERIMENTAL
Intervention: Fenbufen (600 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Indomethacin (75 mg daily)
Number of subjects: 30
Study: 30969201

Group type: EXPERIMENTAL
Intervention: Ulipristal 5 mg
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: Ulipristal 10 mg
Number of subjects: 589

Group type: COMPARATOR
Intervention: Ulipristal 5 mg and 10 mg
Number of subjects: 589
Study: 30255637

Group type: EXPERIMENTAL
Intervention: Play activities program (1 hour weekly for 8 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Reading books and magazines (15 minutes weekly for 8 weeks)
Number of subjects: 53
Study: 27247219

Group type: EXPERIMENTAL
Intervention: MBSR(BC) program (6 weeks)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Usual care group (control)
Number of subjects: 322
Study: 24878457

Group type: EXPERIMENTAL
Intervention: Early appendectomy (within 24 hours of diagnosis)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Early appendectomy
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Interval appendectomy (4-6 weeks after initial treatment with antibiotics)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Interval appendectomy
Number of subjects: 195
Study: 23076197

Group type: EXPERIMENTAL
Intervention: Ulinastatin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no ulinastatin)
Number of subjects: 40
Study: 20658820

Group type: EXPERIMENTAL
Intervention: High-threat invalid trials (smokers)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: High-threat valid trials (smokers and nonsmokers)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Reaction time measures
Number of subjects: 29
Study: 18321181

Group type: EXPERIMENTAL
Intervention: Follicular phase smoking cessation (n = 25)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Luteal phase smoking cessation (n = 19)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Overall study population (n = 35 who initiated treatment)
Number of subjects: 44
Study: 15557136

Group type: EXPERIMENTAL
Intervention: 500 ppm CO inhalation for 1 hour
Number of subjects: 0

Group type: COMPARATOR
Intervention: Synthetic air (placebo) inhalation
Number of subjects: 0
Study: 12218381

Group type: EXPERIMENTAL
Intervention: High-dose estrogen plus methyltestosterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose estrogen
Number of subjects: 0
Study: 10809858

Group type: EXPERIMENTAL
Intervention: Mixed blue and red light (415 and 660 nm)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Blue light (415 nm)
Number of subjects: 107

Group type: COMPARATOR
Intervention: 5% benzoyl peroxide cream
Number of subjects: 107

Group type: COMPARATOR
Intervention: Cool white light
Number of subjects: 107
Study: 8874253

Group type: EXPERIMENTAL
Intervention: 2 days of i.v. antibiotics followed by 8 days of oral therapy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 5 days of i.v. antibiotics followed by 5 days of oral therapy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 10 days of i.v. antibiotics
Number of subjects: 75

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 75
Study: 1686784

Group type: EXPERIMENTAL
Intervention: Lacidipine (4 mg once a day, at 0700 h)
Number of subjects: 10
Study: 6390331

Group type: EXPERIMENTAL
Intervention: Counseling parents on more effective responses to infant crying
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 31492179

Group type: EXPERIMENTAL
Intervention: Observational cohort
Number of subjects: 1479

Group type: EXPERIMENTAL
Intervention: RCT
Number of subjects: 1479

Group type: COMPARATOR
Intervention: High-flow oxygen therapy
Number of subjects: 1479
Study: 29882087

Group type: EXPERIMENTAL
Intervention: Riociguat 0.5 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Riociguat 1.0 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Biperiden 2.0 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Biperiden 2.0 mg and Riociguat 0.5 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Biperiden 2.0 mg and Riociguat 1.0 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29798272

Group type: EXPERIMENTAL
Intervention: Nasal endoscopic surgery
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conservative treatment (radiotherapy)
Number of subjects: 82
Study: 24878142

Group type: EXPERIMENTAL
Intervention: ReDO programme
Number of subjects: 84

Group type: COMPARATOR
Intervention: CAU (Care as Usual)
Number of subjects: 84